Village Farms (VFF) Q4 2025 earnings review
Record Profits Validate the Pivot, But Capacity Ceilings Cap Q4 Momentum
Village Farms closed out a transformational 2025 by proving its transition away from produce and toward high-margin global cannabis was the right move. Full-year Adjusted EBITDA hit a record $49.9 million, and Q4 net income swung to a positive $2.3 million. The engine behind this profitability is the Canadian Cannabis segment, which posted an impressive 43% gross margin driven by a 384% YoY surge in international exports. However, there is a catch: demand is now severely outpacing the company's production capabilities. As a result, Q4 top-line momentum decelerated sequentially. Management is racing to uncap this bottleneck by bringing the Delta 2 and Netherlands Phase II expansions online in early 2026.
🐂 Bull Case
The strategic decision to stop chasing low-margin value products in Canada and focus on premium exports has structurally transformed earnings. Gross margins in the Canadian Cannabis segment have consistently stayed above the long-term 30-40% target range for the past three quarters.
The company generated $58.1 million in operating cash flow in FY25 and sits on $86 million in cash. This pristine balance sheet allows them to fully fund significant capacity expansions and execute buybacks without diluting shareholders.
🐻 Bear Case
The lack of available supply is actively hurting current results. International export sales actually dropped sequentially in Q4, proving that the company is missing out on immediate revenue while waiting for new cultivation rooms to come online.
The U.S. Cannabis segment remains a persistent drag on the business, with Q4 sales dropping to $3.4 million as state-level crackdowns on intoxicating hemp products strangle the market.
⚖️ Verdict: 🟢
Bullish. While the sequential dip in revenue is frustrating, it represents a 'high-class problem' of excessive demand rather than a loss of market share. Once the new cultivation facilities yield crops in H1 2026, the company is perfectly positioned to resume its explosive growth trajectory.
Key Themes
International Exports Transforming the Margin Profile
Accelerating YoY. International export sales skyrocketed 384% YoY to CAD $12.1 million in Q4. These medical exports to markets like Germany carry significantly higher margins than domestic retail and bypass Canada's punitive excise taxes. This mix-shift is the primary reason the company was able to shatter its historical profit records in 2025.
Supply Constraints Choking Sequential Growth
Reversing. Despite management's highly positive narrative regarding global demand, a look at the sequential numbers reveals a concerning bottleneck. International sales fell from CAD $16.3 million in Q3 to CAD $12.1 million in Q4. Management explicitly blamed 'temporary supply constraints', signaling that the company is missing out on sales until its new facilities are finished.
Massive Capacity Injections Underway
Accelerating. To fix the supply squeeze, Village Farms is aggressively expanding. Cultivation began in the Delta 2 expansion in March, which will add 15 incremental tonnes of capacity in 2026 (scaling to 40 tonnes). In the Netherlands, Phase II planting begins in Q1, quintupling the local capacity to 10 tonnes. This sets up a strong supply tailwind for the second half of 2026.
Specific Product & Packaging Innovations
Stable. The company is leaning into premiumization to defend shelf space in the highly competitive Canadian domestic market. Recent specific launches include a one-way aroma valve built directly into dried flower packaging, windowed bags, and a proprietary built-in matchbox accessory for pre-rolls to cater to the 'ready-to-enjoy' consumer segment.
U.S. Hemp Business Continues to Decay
Decelerating. Sales at the U.S. Cannabis segment (Balanced Health Botanicals) dropped to $3.4 million from $4.6 million a year ago, and gross margins compressed by 10 full percentage points down to 60%. The proliferation of unregulated products and confusing state-level restrictions continue to suffocate this business unit.
Macro Tailwind: U.S. Rescheduling on the Horizon
Stable. Management cited an evolving macro landscape, specifically pointing to President Trump's Executive Order to reschedule marijuana. While immediate operational impacts are zero, rescheduling represents a critical step toward modernizing U.S. policy, which Village Farms plans to exploit via its 4.2 million square feet of retained Texas greenhouse assets.
Other KPIs
Stable. While slightly down from the record 56% achieved in Q3 (which management previously warned was exceptionally high), a 43% margin remains incredibly strong and firmly beats the company's long-term target of 30-40%. By comparison, Q4 2024 gross margin was 2% due to severe non-cash inventory impairments.
Accelerating. Up massively from $13.7 million in FY24. This robust cash generation proves that the underlying business model is fundamentally sound after shedding the volatile produce operations, allowing management to repurchase $6.7 million in shares since Q3 while still growing the cash pile to $86 million.
Guidance
Accelerating. The facility commenced cultivation on March 2. This partial rollout will alleviate immediate supply bottlenecks in H2 2026, eventually scaling to add 40 tonnes of annualized capacity (+33% to total Canadian capacity).
Reversing. After the sequential dip experienced in Q4 (from CAD 16.3M to CAD 12.1M), management officially guided that Q1 2026 will return to positive sequential growth, suggesting immediate supply chain fixes have been implemented.
Key Questions
Bridging the Supply Gap
International sales fell sequentially in Q4 despite surging global demand. How much revenue exactly do you estimate was left on the table this quarter, and what interim measures are being taken before Delta 2 yields its first harvest?
Netherlands Margins & OpEx
Net sales in the Netherlands were $3.3 million, but the segment posted a net loss due to scaling expenses for Phase II. When do you expect the Netherlands segment to cross back into sustained profitability?
Texas License Pathway
With the Texas DPS set to award new medicinal marijuana licenses on or before April 1, 2026, what are the immediate CapEx requirements if Village Farms is awarded a license, and how quickly can the Texas greenhouses be converted to active cultivation?